Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	NFYA NFYC SOX5 CCAR1 BPTF SP1 SP2 GTF2A1 SP4 FOXP4 RFX2 CTCF	3.79e-06	1459	35	12	GO:0000977
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	NFYA NFYC SOX5 CCAR1 BPTF SP1 SP2 SP4 FOXP4 RFX2 CTCF	5.46e-06	1244	35	11	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	NFYA NFYC SOX5 CCAR1 BPTF SP1 SP2 SP4 FOXP4 RFX2 CTCF	6.70e-06	1271	35	11	GO:0000987
GeneOntologyMolecularFunction	transcription factor binding	NFYA BPTF SP1 GTF2A1 NCOA6 TAF4 TAF4B CTCF	3.75e-05	753	35	8	GO:0008134
GeneOntologyMolecularFunction	RNA polymerase II general transcription initiation factor activity	GTF2A1 TAF4 TAF4B	1.03e-04	52	35	3	GO:0016251
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	NFYA NFYC SOX5 SP1 SP2 SP4 FOXP4 RFX2 CTCF YLPM1	1.08e-04	1412	35	10	GO:0000981
GeneOntologyMolecularFunction	general transcription initiation factor activity	GTF2A1 TAF4 TAF4B	2.29e-04	68	35	3	GO:0140223
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	SP1 GTF2A1 NCOA6 TAF4 TAF4B CTCF	4.72e-04	582	35	6	GO:0140297
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	SP1 GTF2A1 NCOA6 TAF4 TAF4B	7.51e-04	417	35	5	GO:0061629
GeneOntologyMolecularFunction	transcription coregulator binding	NFYA SP1 CTCF	1.87e-03	140	35	3	GO:0001221
GeneOntologyMolecularFunction	molecular adaptor activity	CCAR1 SUPT20HL1 SP1 NCOA6 SUPT20HL2 GTF2A1L CTCF SYNE1	2.00e-03	1356	35	8	GO:0060090
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity, RNA polymerase II-specific	SP2 FOXP4 CTCF YLPM1	2.29e-03	320	35	4	GO:0001227
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity	SP2 FOXP4 CTCF YLPM1	2.45e-03	326	35	4	GO:0001217
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	NFYA NFYC SP1 RFX2 CTCF	2.76e-03	560	35	5	GO:0001228
GeneOntologyMolecularFunction	transcription coregulator activity	CCAR1 SUPT20HL1 NCOA6 SUPT20HL2 GTF2A1L	2.80e-03	562	35	5	GO:0003712
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	NFYA NFYC SP1 RFX2 CTCF	2.89e-03	566	35	5	GO:0001216
GeneOntologyMolecularFunction	ATP-dependent activity	BPTF TOMM20 CHD8 LONP2 MYO1F	4.09e-03	614	35	5	GO:0140657
GeneOntologyMolecularFunction	core promoter sequence-specific DNA binding	GTF2A1 TAF4	4.18e-03	55	35	2	GO:0001046
GeneOntologyMolecularFunction	protein heterodimerization activity	NFYC GTF2A1 TAF4 TAF4B	5.00e-03	398	35	4	GO:0046982
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	CCAR1 NCOA6	5.12e-03	61	35	2	GO:0030374
GeneOntologyMolecularFunction	modification-dependent protein binding	BPTF CHD8 RAD23A	5.55e-03	206	35	3	GO:0140030
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	GTF2A1 SCAF8	5.97e-03	66	35	2	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	GTF2A1 SCAF8	5.97e-03	66	35	2	GO:0001098
GeneOntologyMolecularFunction	ubiquitin-protein transferase activity	CCAR1 RNF216 MAGEL2 NEURL4	9.11e-03	473	35	4	GO:0004842
GeneOntologyMolecularFunction	methylated histone binding	BPTF CHD8	9.95e-03	86	35	2	GO:0035064
GeneOntologyMolecularFunction	methylation-dependent protein binding	BPTF CHD8	1.04e-02	88	35	2	GO:0140034
GeneOntologyMolecularFunction	ubiquitin-like protein transferase activity	CCAR1 RNF216 MAGEL2 NEURL4	1.19e-02	512	35	4	GO:0019787
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	NFYA NFYC SUPT20HL1 BPTF SP1 GTF2A1 NCOA6 CHD8 SUPT20HL2 TAF4 TAF4B MBTPS2 RFX2 CTCF	2.26e-08	1390	35	14	GO:0045944
GeneOntologyBiologicalProcess	DNA-templated transcription initiation	GTF2A1 NCOA6 TAF4 TAF4B GTF2A1L	4.16e-05	231	35	5	GO:0006352
GeneOntologyBiologicalProcess	in utero embryonic development	SOX5 BPTF SP1 SP2 NCOA6 CHD8 CTCF	5.40e-05	596	35	7	GO:0001701
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	SOX5 CCAR1 BPTF SP2 CHD8 FOXP4 MAGEL2 CTCF SCAF8 YLPM1	7.64e-05	1399	35	10	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	SOX5 CCAR1 BPTF SP2 CHD8 FOXP4 MAGEL2 CTCF SCAF8 YLPM1	8.31e-05	1413	35	10	GO:1902679
GeneOntologyBiologicalProcess	mRNA transcription by RNA polymerase II	SP1 TAF4 TAF4B	9.34e-05	52	35	3	GO:0042789
GeneOntologyBiologicalProcess	embryo development	SOX5 SUPT20HL1 BPTF SP1 SP2 NCOA6 CHD8 FOXP4 SUPT20HL2 CTCF	9.57e-05	1437	35	10	GO:0009790
GeneOntologyBiologicalProcess	mRNA transcription	SP1 TAF4 TAF4B	1.23e-04	57	35	3	GO:0009299
GeneOntologyBiologicalProcess	positive regulation of transcription initiation by RNA polymerase II	GTF2A1 TAF4 TAF4B	2.27e-04	70	35	3	GO:0060261
GeneOntologyBiologicalProcess	RNA polymerase II preinitiation complex assembly	GTF2A1 TAF4 TAF4B	2.36e-04	71	35	3	GO:0051123
GeneOntologyBiologicalProcess	transcription initiation at RNA polymerase II promoter	GTF2A1 TAF4 TAF4B GTF2A1L	2.69e-04	186	35	4	GO:0006367
GeneOntologyBiologicalProcess	positive regulation of DNA-templated transcription initiation	GTF2A1 TAF4 TAF4B	3.00e-04	77	35	3	GO:2000144
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	BPTF SP2 CHD8 FOXP4 MAGEL2 CTCF SCAF8 YLPM1	3.08e-04	1053	35	8	GO:0000122
GeneOntologyBiologicalProcess	regulation of transcription initiation by RNA polymerase II	GTF2A1 TAF4 TAF4B	3.49e-04	81	35	3	GO:0060260
GeneOntologyBiologicalProcess	transcription preinitiation complex assembly	GTF2A1 TAF4 TAF4B	4.02e-04	85	35	3	GO:0070897
GeneOntologyBiologicalProcess	regulation of DNA-templated transcription initiation	GTF2A1 TAF4 TAF4B	4.91e-04	91	35	3	GO:2000142
GeneOntologyBiologicalProcess	chordate embryonic development	SOX5 BPTF SP1 SP2 NCOA6 CHD8 CTCF	7.05e-04	906	35	7	GO:0043009
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	SOX5 BPTF SP1 SP2 NCOA6 CHD8 CTCF	8.17e-04	929	35	7	GO:0009792
GeneOntologyBiologicalProcess	DNA damage response	SUPT20HL1 NCOA6 SUPT20HL2 TAF4 MBTPS2 NEURL4 RAD23A	9.85e-04	959	35	7	GO:0006974
GeneOntologyBiologicalProcess	embryonic placenta development	BPTF SP1 NCOA6	1.07e-03	119	35	3	GO:0001892
GeneOntologyCellularComponent	chromatin	NFYA NFYC SOX5 SUPT20HL1 BPTF SP1 SP2 SP4 CHD8 FOXP4 SUPT20HL2 TOX4 TAF4 RFX2	4.22e-08	1480	35	14	GO:0000785
GeneOntologyCellularComponent	transcription regulator complex	NFYA NFYC SOX5 SP1 GTF2A1 NCOA6 TAF4 TAF4B GTF2A1L	4.27e-07	596	35	9	GO:0005667
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	NFYA NFYC GTF2A1 TAF4 TAF4B GTF2A1L	5.43e-06	272	35	6	GO:0090575
GeneOntologyCellularComponent	nuclear protein-containing complex	NFYA NFYC BPTF GTF2A1 NCOA6 CHD8 TAF4 TAF4B GTF2A1L SCAF8 SYNE1	9.31e-06	1377	35	11	GO:0140513
GeneOntologyCellularComponent	RNA polymerase II, holoenzyme	GTF2A1 TAF4 TAF4B GTF2A1L	1.45e-05	89	35	4	GO:0016591
GeneOntologyCellularComponent	transcription factor TFIIA complex	GTF2A1 GTF2A1L	2.71e-05	5	35	2	GO:0005672
GeneOntologyCellularComponent	nuclear DNA-directed RNA polymerase complex	GTF2A1 TAF4 TAF4B GTF2A1L	3.72e-05	113	35	4	GO:0055029
GeneOntologyCellularComponent	SAGA-type complex	SUPT20HL1 SUPT20HL2 TAF4	3.77e-05	39	35	3	GO:0070461
GeneOntologyCellularComponent	CCAAT-binding factor complex	NFYA NFYC	4.07e-05	6	35	2	GO:0016602
GeneOntologyCellularComponent	DNA-directed RNA polymerase complex	GTF2A1 TAF4 TAF4B GTF2A1L	4.13e-05	116	35	4	GO:0000428
GeneOntologyCellularComponent	RNA polymerase complex	GTF2A1 TAF4 TAF4B GTF2A1L	4.56e-05	119	35	4	GO:0030880
GeneOntologyCellularComponent	transcription factor TFIID complex	GTF2A1 TAF4 TAF4B	6.63e-05	47	35	3	GO:0005669
GeneOntologyCellularComponent	transferase complex	SUPT20HL1 GTF2A1 NCOA6 CHD8 SUPT20HL2 TAF4 TAF4B GTF2A1L	1.53e-04	963	35	8	GO:1990234
GeneOntologyCellularComponent	histone methyltransferase complex	NCOA6 CHD8 TAF4	2.67e-04	75	35	3	GO:0035097
GeneOntologyCellularComponent	male germ cell nucleus	TAF4 GTF2A1L CTCF	4.00e-04	86	35	3	GO:0001673
GeneOntologyCellularComponent	histone acetyltransferase complex	SUPT20HL1 SUPT20HL2 TAF4	5.19e-04	94	35	3	GO:0000123
GeneOntologyCellularComponent	protein acetyltransferase complex	SUPT20HL1 SUPT20HL2 TAF4	6.97e-04	104	35	3	GO:0031248
GeneOntologyCellularComponent	methyltransferase complex	NCOA6 CHD8 TAF4	7.78e-04	108	35	3	GO:0034708
GeneOntologyCellularComponent	SAGA complex	SUPT20HL1 SUPT20HL2	7.97e-04	25	35	2	GO:0000124
GeneOntologyCellularComponent	acetyltransferase complex	SUPT20HL1 SUPT20HL2 TAF4	7.99e-04	109	35	3	GO:1902493
GeneOntologyCellularComponent	germ cell nucleus	TAF4 GTF2A1L CTCF	8.87e-04	113	35	3	GO:0043073
GeneOntologyCellularComponent	intracellular protein-containing complex	SUPT20HL1 GTF2A1 SUPT20HL2 TAF4 TAF4B GTF2A1L RAD23A	9.86e-04	972	35	7	GO:0140535
GeneOntologyCellularComponent	MLL1 complex	CHD8 TAF4	1.31e-03	32	35	2	GO:0071339
GeneOntologyCellularComponent	MLL1/2 complex	CHD8 TAF4	1.39e-03	33	35	2	GO:0044665
GeneOntologyCellularComponent	peptidase complex	SUPT20HL1 SUPT20HL2 RAD23A	1.42e-03	133	35	3	GO:1905368
GeneOntologyCellularComponent	transferase complex, transferring phosphorus-containing groups	GTF2A1 TAF4 TAF4B GTF2A1L	2.29e-03	335	35	4	GO:0061695
HumanPheno	Motor delay	SOX5 BPTF CHD8 QRICH1 MAGEL2 TAF4 MBTPS2 CTCF SYNE1	6.03e-05	1018	12	9	HP:0001270
HumanPheno	Clinodactyly	SOX5 BPTF RNF216 QRICH1 MAGEL2 TAF4 CTCF	1.06e-04	574	12	7	HP:0030084
HumanPheno	Pica	CHD8 TAF4	1.41e-04	8	12	2	HP:0011856
HumanPheno	Open mouth	SOX5 CHD8 MAGEL2 CTCF	1.42e-04	124	12	4	HP:0000194
HumanPheno	Abnormal internal genitalia	SOX5 BPTF RNF216 EYS MAGEL2 TAF4 TAF4B MBTPS2 CTCF SYNE1	1.68e-04	1498	12	10	HP:0000812
HumanPheno	Feeding difficulties	SOX5 BPTF CHD8 QRICH1 MAGEL2 TAF4 MBTPS2 CTCF SYNE1	1.89e-04	1168	12	9	HP:0011968
HumanPheno	Premature adrenarche	MAGEL2 TAF4	2.27e-04	10	12	2	HP:0012412
HumanPheno	Macrotia	QRICH1 TAF4 MBTPS2 CTCF SYNE1	2.39e-04	271	12	5	HP:0000400
HumanPheno	Radial deviation of finger	BPTF RNF216 QRICH1 MAGEL2 TAF4 CTCF	2.61e-04	448	12	6	HP:0009466
HumanPheno	Radial deviation of the hand or of fingers of the hand	BPTF RNF216 QRICH1 MAGEL2 TAF4 CTCF	2.88e-04	456	12	6	HP:0009485
HumanPheno	Abnormality of upper lip vermillion	BPTF CHD8 QRICH1 MAGEL2 TAF4 CTCF	3.17e-04	464	12	6	HP:0011339
HumanPheno	Thick eyebrow	BPTF MAGEL2 TAF4 CTCF	3.29e-04	154	12	4	HP:0000574
HumanPheno	Abnormality of refraction	SOX5 BPTF MAGEL2 TAF4 MBTPS2 CTCF SYNE1	4.12e-04	709	12	7	HP:0000539
HumanPheno	Abnormal pinna morphology	SOX5 BPTF CHD8 QRICH1 MAGEL2 TAF4 MBTPS2 CTCF SYNE1	4.53e-04	1299	12	9	HP:0000377
HumanPheno	Abnormality of the philtrum	BPTF CHD8 QRICH1 MAGEL2 TAF4 CTCF SYNE1	4.78e-04	726	12	7	HP:0000288
HumanPheno	Abnormal 5th finger morphology	BPTF RNF216 QRICH1 TAF4 MBTPS2 CTCF	5.28e-04	509	12	6	HP:0004207
HumanPheno	Kyphosis	SOX5 MAGEL2 TAF4 MBTPS2 CTCF SYNE1	5.33e-04	510	12	6	HP:0002808
HumanPheno	Slanting of the palpebral fissure	SOX5 BPTF CHD8 QRICH1 MAGEL2 TAF4 CTCF	5.35e-04	739	12	7	HP:0200006
HumanPheno	Aggressive behavior	SOX5 BPTF CHD8 MAGEL2 TAF4 CTCF	5.69e-04	516	12	6	HP:0000718
HumanPheno	Abnormal aggressive, impulsive or violent behavior	SOX5 BPTF CHD8 MAGEL2 TAF4 CTCF	5.69e-04	516	12	6	HP:0006919
HumanPheno	Abnormality of the outer ear	SOX5 BPTF CHD8 QRICH1 MAGEL2 TAF4 MBTPS2 CTCF SYNE1	5.72e-04	1337	12	9	HP:0000356
HumanPheno	Upslanted palpebral fissure	BPTF QRICH1 MAGEL2 TAF4 CTCF	6.26e-04	333	12	5	HP:0000582
HumanPheno	Deviation of finger	BPTF RNF216 QRICH1 MAGEL2 TAF4 CTCF	7.07e-04	537	12	6	HP:0004097
HumanPheno	Abnormal finger morphology	SOX5 BPTF RNF216 QRICH1 MAGEL2 TAF4 MBTPS2 CTCF SYNE1	7.61e-04	1385	12	9	HP:0001167
MousePheno	abnormal primitive streak morphology	SUPT20HL1 BPTF CHD8 SUPT20HL2 YLPM1	7.33e-05	201	31	5	MP:0002231
MousePheno	abnormal left-right axis symmetry of the somites	SUPT20HL1 SUPT20HL2	1.32e-04	8	31	2	MP:0005224
MousePheno	abnormal mesoderm morphology	SUPT20HL1 BPTF CHD8 SUPT20HL2	1.69e-04	127	31	4	MP:0014141
MousePheno	abnormal gastrulation movements	SUPT20HL1 SUPT20HL2	2.12e-04	10	31	2	MP:0002174
MousePheno	abnormal germ layer development	SUPT20HL1 BPTF CHD8 SUPT20HL2	2.74e-04	144	31	4	MP:0001674
MousePheno	abnormal fibroblast apoptosis	NFYA NCOA6 TAF4	3.42e-04	62	31	3	MP:0013500
MousePheno	abnormal head fold morphology	SUPT20HL1 SUPT20HL2 YLPM1	3.75e-04	64	31	3	MP:0011257
MousePheno	abnormal germ layer morphology	SUPT20HL1 BPTF CHD8 SUPT20HL2	4.19e-04	161	31	4	MP:0014138
MousePheno	abnormal gastrulation	SUPT20HL1 BPTF SP2 CHD8 SUPT20HL2 YLPM1	4.98e-04	469	31	6	MP:0001695
MousePheno	embryonic lethality during organogenesis	BPTF SP1 SP2 NCOA6 CHD8 FOXP4 TAF4 CTCF	4.98e-04	876	31	8	MP:0006207
MousePheno	abnormal embryo development	SUPT20HL1 BPTF SP2 TOMM20 NCOA6 CHD8 SUPT20HL2 TOX4 CTCF YLPM1	5.11e-04	1370	31	10	MP:0001672
MousePheno	abnormal fibroblast proliferation	NFYA SP2 NCOA6 TAF4	5.73e-04	175	31	4	MP:0011702
MousePheno	abnormal sexual maturation	SP4 MAGEL2 TAF4B	5.75e-04	74	31	3	MP:0001937
MousePheno	embryonic lethality during organogenesis, complete penetrance	BPTF SP1 SP2 NCOA6 CHD8 TAF4 CTCF	7.02e-04	700	31	7	MP:0011098
Domain	Sp1_fam	SP1 SP2 SP4	6.56e-07	10	34	3	IPR030450
Domain	TFIIA_asu/bsu	GTF2A1 GTF2A1L	3.22e-06	2	34	2	IPR004855
Domain	TFIIA	GTF2A1 GTF2A1L	3.22e-06	2	34	2	SM01371
Domain	TFIIA_asu_N	GTF2A1 GTF2A1L	3.22e-06	2	34	2	IPR013028
Domain	TAF4	TAF4 TAF4B	3.22e-06	2	34	2	PF05236
Domain	TFIIA	GTF2A1 GTF2A1L	3.22e-06	2	34	2	PF03153
Domain	-	GTF2A1 GTF2A1L	3.22e-06	2	34	2	1.10.287.100
Domain	TAF4	TAF4 TAF4B	3.22e-06	2	34	2	IPR007900
Domain	-	GTF2A1 GTF2A1L	9.64e-06	3	34	2	2.30.18.10
Domain	TFIIA_b-brl	GTF2A1 GTF2A1L	9.64e-06	3	34	2	IPR009088
Domain	TFIIA_a-hlx	GTF2A1 GTF2A1L	1.93e-05	4	34	2	IPR009083
Domain	TAFH	TAF4 TAF4B	3.21e-05	5	34	2	PS51119
Domain	TAFH	TAF4 TAF4B	3.21e-05	5	34	2	SM00549
Domain	TAFH	TAF4 TAF4B	3.21e-05	5	34	2	PF07531
Domain	TAFH_NHR1	TAF4 TAF4B	3.21e-05	5	34	2	IPR003894
Domain	-	NFYC TAF4 TAF4B	2.66e-04	69	34	3	1.10.20.10
Domain	Histone-fold	NFYC TAF4 TAF4B	4.58e-04	83	34	3	IPR009072
Domain	HMG_box	SOX5 TOX4	4.18e-03	53	34	2	PF00505
Domain	HMG_BOX_2	SOX5 TOX4	4.34e-03	54	34	2	PS50118
Domain	HMG	SOX5 TOX4	4.34e-03	54	34	2	SM00398
Domain	-	SOX5 TOX4	4.50e-03	55	34	2	1.10.30.10
Domain	HMG_box_dom	SOX5 TOX4	6.23e-03	65	34	2	IPR009071
Domain	ZINC_FINGER_C2H2_2	SP1 SP2 SP4 FOXP4 CTCF	1.24e-02	775	34	5	PS50157
Domain	ZINC_FINGER_C2H2_1	SP1 SP2 SP4 FOXP4 CTCF	1.26e-02	777	34	5	PS00028
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	NFYA NFYC SP1 NCOA6 MBTPS2	3.01e-08	55	24	5	M27001
Pathway	BIOCARTA_TERC_PATHWAY	NFYA NFYC SP1	8.64e-08	6	24	3	MM1564
Pathway	BIOCARTA_TERC_PATHWAY	NFYA NFYC SP1	8.64e-08	6	24	3	M22047
Pathway	KEGG_BASAL_TRANSCRIPTION_FACTORS	GTF2A1 TAF4 TAF4B GTF2A1L	3.27e-07	35	24	4	M4864
Pathway	REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	NFYA NFYC SP1 NCOA6	6.93e-07	42	24	4	M27172
Pathway	REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES	NFYA NFYC MBTPS2	9.44e-07	12	24	3	M794
Pathway	REACTOME_METABOLISM_OF_STEROIDS	NFYA NFYC SP1 NCOA6 MBTPS2	5.24e-06	154	24	5	M27832
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NFYA NFYC SP1 NCOA6	4.36e-05	118	24	4	M27316
Pathway	REACTOME_HIV_TRANSCRIPTION_INITIATION	GTF2A1 TAF4 TAF4B	6.69e-05	47	24	3	M29568
Pathway	REACTOME_RNA_POLYMERASE_II_PROMOTER_ESCAPE	GTF2A1 TAF4 TAF4B	7.13e-05	48	24	3	MM15424
Pathway	REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES	NFYA NFYC	1.24e-04	10	24	2	M801
Pathway	WP_SIDS_SUSCEPTIBILITY_PATHWAYS	NFYA SP1 CTCF	1.32e-04	59	24	3	MM15838
Pathway	PID_MYC_REPRESS_PATHWAY	NFYA NFYC SP1	1.61e-04	63	24	3	M254
Pathway	REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME	GTF2A1 TAF4 TAF4B	2.20e-04	70	24	3	M27008
Pathway	WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING	NFYA SP1 MBTPS2	2.30e-04	71	24	3	M39395
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES	NFYA NFYC	3.29e-04	16	24	2	M27940
Pathway	REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS	GTF2A1 TAF4 TAF4B	3.39e-04	81	24	3	M865
Pathway	REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS	GTF2A1 TAF4 TAF4B	3.64e-04	83	24	3	MM15314
Pathway	REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR	NFYA NFYC MBTPS2	5.09e-04	93	24	3	M10294
Pathway	REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS	NFYA NFYC	9.50e-04	27	24	2	M796
Pathway	WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY	SP1 NCOA6	1.25e-03	31	24	2	M39476
Pathway	REACTOME_PERK_REGULATES_GENE_EXPRESSION	NFYA NFYC	1.34e-03	32	24	2	M792
Pathway	PID_P53_DOWNSTREAM_PATHWAY	NFYA NFYC SP1	1.57e-03	137	24	3	M145
Pathway	WP_ENDODERM_DIFFERENTIATION	BPTF SP4 TAF4B	1.77e-03	143	24	3	M39591
Pathway	REACTOME_HIV_LIFE_CYCLE	GTF2A1 TAF4 TAF4B	1.99e-03	149	24	3	M4076
Pathway	WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS	NFYA SP1 CTCF	2.39e-03	159	24	3	M39373
Pathway	WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME	SP1 CTCF	2.75e-03	46	24	2	MM15949
Pathway	KEGG_HUNTINGTONS_DISEASE	SP1 TAF4 TAF4B	3.51e-03	182	24	3	M13486
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	SP1 GTF2A1	5.09e-03	63	24	2	MM15613
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	NFYA NFYC SOX5 CCAR1 BPTF SP1 SP2 GTF2A1 SP4 TOX4 RFX2 CTCF	1.71e-11	808	36	12	20412781
Pubmed	Human transcription factor protein interaction networks.	NFYA NFYC SOX5 CCAR1 BPTF SP1 SP2 NCOA6 CHD8 FOXP4 TAF4 CTCF SCAF8 YLPM1	5.96e-11	1429	36	14	35140242
Pubmed	Sp2 is the only glutamine-rich specificity protein with minor impact on development and differentiation in myelinating glia.	SP1 SP2 SP4	4.07e-09	4	36	3	27889927
Pubmed	Regulation of expression of the chorionic gonadotropin/luteinizing hormone receptor gene in the human myometrium: involvement of specificity protein-1 (Sp1), Sp3, Sp4, Sp-like proteins, and histone deacetylases.	SP1 SP2 SP4	4.07e-09	4	36	3	15788387
Pubmed	Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.	SP1 SP2 SP4	1.02e-08	5	36	3	10547281
Pubmed	A census of human transcription factors: function, expression and evolution.	NFYA NFYC SOX5 SP1 SP2 SP4 FOXP4 TOX4 RFX2 CTCF	1.92e-08	908	36	10	19274049
Pubmed	Transcriptional regulation of P450scc gene expression in the embryonic rodent nervous system.	SP1 SP2 SP4	2.03e-08	6	36	3	14576192
Pubmed	Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells.	SP1 SP2 SP4	2.03e-08	6	36	3	16201967
Pubmed	Core promoter binding by histone-like TAF complexes.	GTF2A1 TAF4 TAF4B	5.68e-08	8	36	3	15601843
Pubmed	Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat.	SP1 GTF2A1 TAF4 TAF4B	1.53e-07	46	36	4	8849451
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	SP1 CHD8 QRICH1 TOX4 CTCF LONP2 YLPM1	1.87e-07	410	36	7	26949251
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	BPTF GTF2A1 NCOA6 CHD8 TOX4 YLPM1	4.37e-07	283	36	6	30585729
Pubmed	A human MAP kinase interactome.	NFYA NFYC SP1 GTF2A1 CHD8 TOX4 SYNE1	5.86e-07	486	36	7	20936779
Pubmed	Architecture of TAF11/TAF13/TBP complex suggests novel regulation properties of general transcription factor TFIID.	GTF2A1 TAF4 TAF4B	8.22e-07	18	36	3	29111974
Pubmed	Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex.	GTF2A1 TAF4 TAF4B	9.76e-07	19	36	3	8764062
Pubmed	CTCF and Sp1 interact with the Murine gammaherpesvirus 68 internal repeat elements.	SP1 CTCF	1.04e-06	2	36	2	22706977
Pubmed	O-GlcNAcylation of Sp1 interrupts Sp1 interaction with NF-Y.	NFYA SP1	1.04e-06	2	36	2	19302979
Pubmed	CTCF-dependent chromatin insulator is linked to epigenetic remodeling.	CHD8 CTCF	1.04e-06	2	36	2	16949368
Pubmed	Increased SP4 and SP1 transcription factor expression in the postmortem hippocampus of chronic schizophrenia.	SP1 SP4	1.04e-06	2	36	2	25175639
Pubmed	Structural changes in TAF4b-TFIID correlate with promoter selectivity.	TAF4 TAF4B	1.04e-06	2	36	2	18206971
Pubmed	Identification of heteromolecular binding sites in transcription factors Sp1 and TAF4 using high-resolution nuclear magnetic resonance spectroscopy.	SP1 TAF4	1.04e-06	2	36	2	28857320
Pubmed	Distinct subdomains of human TAFII130 are required for interactions with glutamine-rich transcriptional activators.	SP1 TAF4	1.04e-06	2	36	2	9742090
Pubmed	Interaction between intrinsically disordered regions in transcription factors Sp1 and TAF4.	SP1 TAF4	1.04e-06	2	36	2	27515574
Pubmed	Reduced expression of SP1 and SP4 transcription factors in peripheral blood mononuclear cells in first-episode psychosis.	SP1 SP4	1.04e-06	2	36	2	23941741
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	BPTF NCOA6 CHD8 TOX4 TAF4 AMOTL2 YLPM1	1.32e-06	549	36	7	38280479
Pubmed	Interaction network of human early embryonic transcription factors.	SOX5 BPTF NCOA6 CHD8 FOXP4 TAF4	1.53e-06	351	36	6	38297188
Pubmed	Mammalian SP/KLF transcription factors: bring in the family.	SP1 SP2 SP4	2.31e-06	25	36	3	15820306
Pubmed	An expanded Oct4 interaction network: implications for stem cell biology, development, and disease.	NFYC SP1 AMOTL2 RFX2	2.42e-06	91	36	4	20362542
Pubmed	Functional interactions between NURF and Ctcf regulate gene expression.	BPTF CTCF	3.12e-06	3	36	2	25348714
Pubmed	Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.	NFYA SP1	3.12e-06	3	36	2	10446910
Pubmed	Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.	SP1 TAF4	3.12e-06	3	36	2	11988536
Pubmed	A transcription factor IIA-binding site differentially regulates RNA polymerase II-mediated transcription in a promoter context-dependent manner.	GTF2A1 TAF4	3.12e-06	3	36	2	28539359
Pubmed	Epigenetic role of CCAAT box-binding transcription factor NF-Y on ID gene family in human embryonic carcinoma cells.	NFYA NFYC	3.12e-06	3	36	2	26509926
Pubmed	Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox.	NFYA NFYC	3.12e-06	3	36	2	8910521
Pubmed	TAF4 inactivation reveals the 3 dimensional growth promoting activities of collagen 6A3.	TAF4 TAF4B	3.12e-06	3	36	2	24498316
Pubmed	Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms.	SP1 SP4	3.12e-06	3	36	2	23540600
Pubmed	Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes.	NFYA SP1	3.12e-06	3	36	2	18654640
Pubmed	Nuclear factor Y (NF-Y) and cellular senescence.	NFYA NFYC	3.12e-06	3	36	2	10585259
Pubmed	Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1.	NFYA SP1	3.12e-06	3	36	2	10393239
Pubmed	Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.	SP1 SP4	3.12e-06	3	36	2	26967243
Pubmed	Curcumin decreases specificity protein expression in bladder cancer cells.	SP1 SP4	3.12e-06	3	36	2	18593936
Pubmed	Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.	SP1 SP4	3.12e-06	3	36	2	21919647
Pubmed	O-GlcNAc modification of Sp3 and Sp4 transcription factors negatively regulates their transcriptional activities.	SP2 SP4	3.12e-06	3	36	2	26431879
Pubmed	The p38-interacting protein (p38IP) regulates G2/M progression by promoting α-tubulin acetylation via inhibiting ubiquitination-induced degradation of the acetyltransferase GCN5.	SUPT20HL1 SUPT20HL2	3.12e-06	3	36	2	24220028
Pubmed	Synergistic regulation of human cystathionine-beta-synthase-1b promoter by transcription factors NF-YA isoforms and Sp1.	NFYA SP1	3.12e-06	3	36	2	12427542
Pubmed	Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.	SP1 SP4	3.12e-06	3	36	2	15345676
Pubmed	Sequence-specific transcription factor NF-Y displays histone-like DNA binding and H2B-like ubiquitination.	NFYA NFYC	3.12e-06	3	36	2	23332751
Pubmed	Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer.	CHD8 CTCF	3.12e-06	3	36	2	25499215
Pubmed	Zinc finger independent genome-wide binding of Sp2 potentiates recruitment of histone-fold protein Nf-y distinguishing it from Sp1 and Sp3.	SP1 SP2	3.12e-06	3	36	2	25793500
Pubmed	Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene.	SP1 SP4	3.12e-06	3	36	2	11532028
Pubmed	Histone-fold domain protein NF-Y promotes chromatin accessibility for cell type-specific master transcription factors.	NFYA NFYC	3.12e-06	3	36	2	25132174
Pubmed	The molecular biology of the CCAAT-binding factor NF-Y.	NFYA NFYC	3.12e-06	3	36	2	10571030
Pubmed	Gene expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y and FOXO transcription factors.	NFYC SP1	3.12e-06	3	36	2	22412893
Pubmed	Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3.	SP1 SP4	3.12e-06	3	36	2	7559627
Pubmed	The human SPT20-containing SAGA complex plays a direct role in the regulation of endoplasmic reticulum stress-induced genes.	SUPT20HL1 SUPT20HL2 TAF4	3.28e-06	28	36	3	19114550
Pubmed	A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing.	SUPT20HL1 SUPT20HL2 TAF4	4.06e-06	30	36	3	18206972
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	CCAR1 BPTF NCOA6 CHD8 TOX4 TAF4 CTCF YLPM1	4.76e-06	954	36	8	36373674
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SP1 NCOA6 SP4 MAGEL2 NEURL4 YLPM1	4.91e-06	430	36	6	35044719
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	CCAR1 BPTF SP1 SP2 NCOA6 TOX4 TAF4 CTCF YLPM1	5.04e-06	1294	36	9	30804502
Pubmed	Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo.	SUPT20HL1 SUPT20HL2 TAF4	5.44e-06	33	36	3	11564863
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	CCAR1 BPTF CHD8 TOX4 CTCF	5.91e-06	251	36	5	31076518
Pubmed	Sp4 is expressed in retinal neurons, activates transcription of photoreceptor-specific genes, and synergizes with Crx.	SP1 SP4	6.24e-06	4	36	2	15781457
Pubmed	Endoplasmic reticulum stress-induced formation of transcription factor complex ERSF including NF-Y (CBF) and activating transcription factors 6alpha and 6beta that activates the mammalian unfolded protein response.	NFYA NFYC	6.24e-06	4	36	2	11158310
Pubmed	NF-Y binding is required for transactivation of neuronal aromatic L-amino acid decarboxylase gene promoter by the POU-domain protein Brn-2.	NFYA NFYC	6.24e-06	4	36	2	11311976
Pubmed	NF-Y recruits Ash2L to impart H3K4 trimethylation on CCAAT promoters.	NFYA NFYC	6.24e-06	4	36	2	21445285
Pubmed	Transcription factor NF-Y is a functional regulator of the transcription of core clock gene Bmal1.	NFYA SP1	6.24e-06	4	36	2	24030830
Pubmed	SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5.	SOX5 SP1	6.24e-06	4	36	2	30819403
Pubmed	TAF4/4b x TAF12 displays a unique mode of DNA binding and is required for core promoter function of a subset of genes.	TAF4 TAF4B	6.24e-06	4	36	2	19635797
Pubmed	A role for nucleoprotein Zap3 in the reduction of telomerase activity during embryonic stem cell differentiation.	SP1 YLPM1	6.24e-06	4	36	2	15511642
Pubmed	Functional interaction between the DNA binding subunit trimerization domain of NF-Y and the high mobility group protein HMG-I(Y).	NFYA NFYC	6.24e-06	4	36	2	9388234
Pubmed	Transcriptional modulation of the pre-implantation embryo-specific Rnf35 gene by the Y-box protein NF-Y/CBF.	NFYA NFYC	6.24e-06	4	36	2	15516209
Pubmed	Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase expression by decreasing the Sp1 and NF-YA transcription factors in the A549 and MCF-7 cells.	NFYA SP1	6.24e-06	4	36	2	30392062
Pubmed	NF-Y affects histone acetylation and H2A.Z deposition in cell cycle promoters.	NFYA NFYC	6.24e-06	4	36	2	21304275
Pubmed	Transcriptional regulation of the Alström syndrome gene ALMS1 by members of the RFX family and Sp1.	SP1 RFX2	6.24e-06	4	36	2	20381594
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	BPTF NCOA6 TOX4 RAD23A	7.05e-06	119	36	4	23508102
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SOX5 SP1 SP2 GTF2A1 FOXP4 QRICH1 TOX4	7.09e-06	709	36	7	22988430
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CCAR1 BPTF CHD8 QRICH1 TAF4 CTCF YLPM1 RAD23A	7.44e-06	1014	36	8	32416067
Pubmed	The general transcription factors of RNA polymerase II.	GTF2A1 TAF4 TAF4B	9.07e-06	39	36	3	8946909
Pubmed	Three transitions in the RNA polymerase II transcription complex during initiation.	GTF2A1 TAF4 TAF4B	9.07e-06	39	36	3	9405375
Pubmed	Abortive initiation is increased only for the weakest members of a set of down mutants of the adenovirus 2 major late promoter.	GTF2A1 TAF4 TAF4B	9.80e-06	40	36	3	1939271
Pubmed	ATP activates transcription initiation from promoters by RNA polymerase II in a reversible step prior to RNA synthesis.	GTF2A1 TAF4 TAF4B	9.80e-06	40	36	3	2449431
Pubmed	Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function.	NFYA NFYC	1.04e-05	5	36	2	12482752
Pubmed	Bone morphogenetic protein 2 mediates dentin sialophosphoprotein expression and odontoblast differentiation via NF-Y signaling.	NFYA NFYC	1.04e-05	5	36	2	18424784
Pubmed	TFIIAalpha/beta-like factor is encoded by a germ cell-specific gene whose expression is up-regulated with other general transcription factors during spermatogenesis in the mouse.	GTF2A1 GTF2A1L	1.04e-05	5	36	2	11159353
Pubmed	Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.	NFYA NFYC	1.04e-05	5	36	2	15831478
Pubmed	Reciprocal regulation of expression of the human adenosine 5'-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors.	SP1 SP4	1.04e-05	5	36	2	12560508
Pubmed	Developmental and cell type-specific regulation of core promoter transcription factors in germ cells of frogs and mice.	GTF2A1 GTF2A1L	1.04e-05	5	36	2	16412700
Pubmed	Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.	SP1 SP4	1.04e-05	5	36	2	20538607
Pubmed	Identification of the G13 (cAMP-response-element-binding protein-related protein) gene product related to activating transcription factor 6 as a transcriptional activator of the mammalian unfolded protein response.	NFYA NFYC	1.04e-05	5	36	2	11256944
Pubmed	Transcriptional regulation of N-acetylglutamate synthase.	NFYA SP1	1.04e-05	5	36	2	22383952
Pubmed	Identification of a general transcription factor TFIIAalpha/beta homolog selectively expressed in testis.	GTF2A1 GTF2A1L	1.04e-05	5	36	2	10364255
Pubmed	NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.	BPTF CHD8	1.04e-05	5	36	2	26626481
Pubmed	ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1.	SP1 TAF4	1.04e-05	5	36	2	12771217
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	CCAR1 BPTF NCOA6 SP4 CHD8 QRICH1 TAF4 RAD23A	1.37e-05	1103	36	8	34189442
Pubmed	p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y.	NFYA NFYC	1.56e-05	6	36	2	14586402
Pubmed	Differential intranuclear organization of transcription factors Sp1 and Sp3.	SP1 SP2	1.56e-05	6	36	2	15987735
Pubmed	Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway.	NFYA NFYC	1.56e-05	6	36	2	12857729
Pubmed	Positive and negative TAF(II) functions that suggest a dynamic TFIID structure and elicit synergy with traps in activator-induced transcription.	GTF2A1 TAF4	1.56e-05	6	36	2	11564872
Pubmed	The transcription factor Sp1 modulates RNA polymerase III gene transcription by controlling BRF1 and GTF3C2 expression in human cells.	SP1 GTF2A1	1.56e-05	6	36	2	32115405
Pubmed	Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.	NFYA SP1	1.56e-05	6	36	2	15647279
Interaction	GTF2A1 interactions	NFYA SP1 SP2 GTF2A1 NCOA6 SP4 TAF4 TAF4B	8.02e-12	104	35	8	int:GTF2A1
Interaction	SRF interactions	NFYA NFYC BPTF SP1 SP2 NCOA6 FOXP4	3.65e-09	139	35	7	int:SRF
Interaction	SP2 interactions	NFYC SP1 SP2 GTF2A1 QRICH1	6.47e-09	39	35	5	int:SP2
Interaction	TBP interactions	NFYA NFYC SP1 GTF2A1 NCOA6 TAF4 TAF4B GTF2A1L	9.70e-09	253	35	8	int:TBP
Interaction	NFYC interactions	NFYA NFYC SP1 SP2 SP4 TAF4 MBTPS2	1.96e-08	177	35	7	int:NFYC
Interaction	POU5F1 interactions	NFYC SOX5 BPTF SP1 FOXP4 TOX4 AMOTL2 RFX2 SCAF8	4.88e-07	584	35	9	int:POU5F1
Interaction	NFYA interactions	NFYA NFYC SP1 GTF2A1 QRICH1	1.00e-06	105	35	5	int:NFYA
Interaction	MKI67 interactions	SP1 NCOA6 CHD8 FOXP4 QRICH1 TOX4 CTCF LONP2 YLPM1	1.16e-06	648	35	9	int:MKI67
Interaction	SP4 interactions	NFYC SP1 GTF2A1 SP4	1.18e-06	46	35	4	int:SP4
Interaction	FEV interactions	SOX5 SP2 NCOA6 FOXP4 TAF4 CTCF	1.23e-06	203	35	6	int:FEV
Interaction	TAF11 interactions	NFYA NFYC TAF4 TAF4B	1.80e-06	51	35	4	int:TAF11
Interaction	ELF1 interactions	NFYA NFYC BPTF SP1 TAF4	2.46e-06	126	35	5	int:ELF1
Interaction	SP1 interactions	NFYA NFYC SP1 SP2 GTF2A1 SP4 TAF4	2.62e-06	365	35	7	int:SP1
Interaction	FHL2 interactions	NFYC CCAR1 SP1 SP2 SP4 QRICH1 MAGEL2	4.49e-06	396	35	7	int:FHL2
Interaction	CREB1 interactions	NFYA SP1 GTF2A1 CHD8 TOX4 TAF4	4.51e-06	254	35	6	int:CREB1
Interaction	CRX interactions	NFYC SOX5 SP1 SP4 FOXP4 QRICH1	4.51e-06	254	35	6	int:CRX
Interaction	POGZ interactions	NFYA NFYC SOX5 SP1 SP4 QRICH1	5.76e-06	265	35	6	int:POGZ
Interaction	YY1 interactions	BPTF SP1 CHD8 FOXP4 TOX4 TAF4 CTCF	1.10e-05	454	35	7	int:YY1
Interaction	GTF2A2 interactions	GTF2A1 TAF4 GTF2A1L	1.21e-05	26	35	3	int:GTF2A2
Interaction	SP7 interactions	SOX5 CCAR1 NCOA6 FOXP4 SCAF8 YLPM1	1.26e-05	304	35	6	int:SP7
Interaction	SMG7 interactions	CCAR1 TOMM20 NCOA6 CHD8 SCAF8 YLPM1	1.65e-05	319	35	6	int:SMG7
Interaction	KLF8 interactions	SOX5 BPTF SP1 FOXP4 TAF4 CTCF	1.97e-05	329	35	6	int:KLF8
Interaction	TAF12 interactions	NFYA NFYC TAF4 TAF4B	2.66e-05	100	35	4	int:TAF12
Interaction	PAX6 interactions	NFYC SOX5 BPTF NCOA6 QRICH1 CTCF	3.58e-05	366	35	6	int:PAX6
Interaction	TAF7 interactions	GTF2A1 CHD8 TAF4 TAF4B	3.59e-05	108	35	4	int:TAF7
Interaction	PRR20A interactions	NFYC SOX5 GTF2A1 SP4	3.73e-05	109	35	4	int:PRR20A
Interaction	ELK3 interactions	SP2 SP4 FOXP4 TAF4	5.43e-05	120	35	4	int:ELK3
Interaction	TRB interactions	NCOA6 CTCF	6.12e-05	7	35	2	int:TRB
Interaction	TAF6 interactions	NFYA NFYC SOX5 GTF2A1 TAF4	6.14e-05	245	35	5	int:TAF6
Interaction	TAF1 interactions	GTF2A1 CHD8 FOXP4 TAF4 TAF4B	8.14e-05	260	35	5	int:TAF1
Interaction	ASH2L interactions	SP1 NCOA6 CHD8 TAF4 C21orf58	8.90e-05	265	35	5	int:ASH2L
Interaction	TBPL1 interactions	GTF2A1 TAF4 GTF2A1L	9.44e-05	51	35	3	int:TBPL1
Interaction	QRICH1 interactions	NFYA SP2 QRICH1 TOX4	9.88e-05	140	35	4	int:QRICH1
Interaction	NKX3-1 interactions	SP1 SP2 SP4	1.00e-04	52	35	3	int:NKX3-1
Interaction	SMAD3 interactions	NFYC BPTF SP1 NCOA6 CHD8 CTCF	1.08e-04	447	35	6	int:SMAD3
Interaction	RFXANK interactions	NFYC BPTF FOXP4 QRICH1	1.16e-04	146	35	4	int:RFXANK
Interaction	KLF15 interactions	NFYC SP2 FOXP4 TAF4 CTCF	1.36e-04	290	35	5	int:KLF15
Interaction	SF3A1 interactions	CCAR1 SP1 TOX4 TAF4 SYNE1 YLPM1	1.44e-04	471	35	6	int:SF3A1
Interaction	TAF4 interactions	NFYC SP1 GTF2A1 TAF4	1.50e-04	156	35	4	int:TAF4
Interaction	XRCC6 interactions	NFYA NFYC BPTF GTF2A1 NCOA6 CHD8 TOX4 YLPM1	1.52e-04	928	35	8	int:XRCC6
Interaction	TBPL2 interactions	NFYC GTF2A1	1.60e-04	11	35	2	int:TBPL2
Interaction	NFYB interactions	NFYA NFYC SP1	1.95e-04	65	35	3	int:NFYB
Interaction	PHAX interactions	NFYA CHD8 CTCF RAD23A	1.95e-04	167	35	4	int:PHAX
Interaction	CEBPA interactions	NFYA CCAR1 BPTF NCOA6 SP4 CHD8 QRICH1 TAF4 RAD23A	2.08e-04	1245	35	9	int:CEBPA
Interaction	SETD1A interactions	NFYC NCOA6 CHD8 CTCF	2.09e-04	170	35	4	int:SETD1A
Interaction	ATF6B interactions	NFYA NFYC MBTPS2	2.23e-04	68	35	3	int:ATF6B
Interaction	POU2F1 interactions	NFYA SOX5 SP1 SP4	2.33e-04	175	35	4	int:POU2F1
Interaction	MAP7D2 interactions	TOMM20 LONP2 NEURL4	2.43e-04	70	35	3	int:MAP7D2
Interaction	FOXP2 interactions	SOX5 SP4 FOXP4	2.43e-04	70	35	3	int:FOXP2
Interaction	SMC5 interactions	CCAR1 BPTF NCOA6 CHD8 TOX4 TAF4 CTCF YLPM1	2.54e-04	1000	35	8	int:SMC5
Interaction	GATA3 interactions	CCAR1 SP1 TOX4 CTCF	3.00e-04	187	35	4	int:GATA3
Interaction	KPNA1 interactions	CCAR1 BPTF CHD8 CTCF YLPM1	3.29e-04	351	35	5	int:KPNA1
Interaction	TERF2IP interactions	CCAR1 BPTF NCOA6 CHD8 TAF4 CTCF	3.39e-04	552	35	6	int:TERF2IP
Interaction	FOXJ2 interactions	NFYC QRICH1 RFX2	3.73e-04	81	35	3	int:FOXJ2
Interaction	ARID4B interactions	NFYC SOX5 BPTF SP1	3.80e-04	199	35	4	int:ARID4B
Interaction	E2F1 interactions	SP1 SP2 NCOA6 SP4	3.87e-04	200	35	4	int:E2F1
Interaction	RETNLB interactions	LONP2 NEURL4	3.92e-04	17	35	2	int:RETNLB
Interaction	USF1 interactions	NFYA BPTF CHD8	4.30e-04	85	35	3	int:USF1
Interaction	SPATA25 interactions	TAF4 TAF4B	4.41e-04	18	35	2	int:SPATA25
Interaction	DNAAF6 interactions	CCAR1 QRICH1	4.41e-04	18	35	2	int:DNAAF6
Interaction	TAF5 interactions	NFYC GTF2A1 TAF4	4.45e-04	86	35	3	int:TAF5
Interaction	PCGF1 interactions	SOX5 CCAR1 CTCF YLPM1	4.49e-04	208	35	4	int:PCGF1
Interaction	TLE3 interactions	CCAR1 RNF216 QRICH1 TAF4 SCAF8	4.51e-04	376	35	5	int:TLE3
Interaction	PRR20B interactions	NFYC GTF2A1 SP4	5.08e-04	90	35	3	int:PRR20B
Interaction	PRR20C interactions	NFYC GTF2A1 SP4	5.08e-04	90	35	3	int:PRR20C
Interaction	PRR20D interactions	NFYC GTF2A1 SP4	5.08e-04	90	35	3	int:PRR20D
Interaction	CEP76 interactions	NFYC EP400P1 NEURL4 RAD23A	5.36e-04	218	35	4	int:CEP76
Interaction	POU3F2 interactions	NFYA NFYC	5.46e-04	20	35	2	int:POU3F2
Interaction	SOX2 interactions	SOX5 BPTF SP2 NCOA6 CHD8 FOXP4 AMOTL2 CTCF YLPM1	5.57e-04	1422	35	9	int:SOX2
Interaction	NFIX interactions	SOX5 BPTF QRICH1 TAF4	6.24e-04	227	35	4	int:NFIX
Interaction	KLF3 interactions	SOX5 BPTF FOXP4 TAF4	6.34e-04	228	35	4	int:KLF3
Interaction	PRR20E interactions	NFYC GTF2A1 SP4	7.12e-04	101	35	3	int:PRR20E
Interaction	TAF4B interactions	GTF2A1 TAF4B	7.25e-04	23	35	2	int:TAF4B
Interaction	WWTR1 interactions	BPTF NCOA6 CHD8 TOX4 AMOTL2	7.60e-04	422	35	5	int:WWTR1
Interaction	NUP35 interactions	NCOA6 QRICH1 SCAF8 SYNE1 YLPM1	7.77e-04	424	35	5	int:NUP35
Interaction	HOXC11 interactions	SP1 GTF2A1L	7.90e-04	24	35	2	int:HOXC11
Interaction	CDC23 interactions	NFYC SOX5 TOMM20 TAF4	7.93e-04	242	35	4	int:CDC23
Interaction	BRD2 interactions	BPTF CHD8 TAF4 TAF4B CTCF	8.19e-04	429	35	5	int:BRD2
Interaction	EMX1 interactions	GTF2A1 GTF2A1L	8.57e-04	25	35	2	int:EMX1
Interaction	PML interactions	SP1 RNF216 SP2 TOMM20 CHD8 QRICH1 TAF4	9.61e-04	933	35	7	int:PML
Interaction	CIC interactions	NFYC SOX5 CCAR1 CHD8 TAF4 CTCF	9.63e-04	673	35	6	int:CIC
Interaction	MAFA interactions	TOMM20 NCOA6	1.00e-03	27	35	2	int:MAFA
Interaction	ELF4 interactions	BPTF SP2 TAF4	1.04e-03	115	35	3	int:ELF4
Interaction	KLHDC7B interactions	NFYC QRICH1	1.08e-03	28	35	2	int:KLHDC7B
Interaction	TAF7L interactions	TAF4 TAF4B	1.08e-03	28	35	2	int:TAF7L
Interaction	ATF6 interactions	NFYA NFYC SP1	1.09e-03	117	35	3	int:ATF6
Interaction	TOP1 interactions	NFYA NFYC CCAR1 NCOA6 TOX4 YLPM1	1.15e-03	696	35	6	int:TOP1
Interaction	SPANXN3 interactions	SP4 RAD23A	1.16e-03	29	35	2	int:SPANXN3
Interaction	HNF4A interactions	BPTF SP1 NCOA6 TAF4	1.27e-03	275	35	4	int:HNF4A
Interaction	BANP interactions	NFYA SP2 SP4 TOX4	1.31e-03	277	35	4	int:BANP
Interaction	BRMS1L interactions	SOX5 BPTF AMOTL2	1.32e-03	125	35	3	int:BRMS1L
Interaction	PROSER1 interactions	SOX5 TOMM20	1.32e-03	31	35	2	int:PROSER1
Interaction	PAX9 interactions	NCOA6 FOXP4 GTF2A1L	1.48e-03	130	35	3	int:PAX9
Interaction	ZBTB7A interactions	SP1 SP4 CHD8	1.51e-03	131	35	3	int:ZBTB7A
Interaction	BRD3 interactions	BPTF CHD8 TAF4 TAF4B CTCF	1.53e-03	494	35	5	int:BRD3
Interaction	PARP1 interactions	NFYA NFYC BPTF SP1 NCOA6 QRICH1 CTCF RAD23A	1.56e-03	1316	35	8	int:PARP1
Interaction	TLX3 interactions	SP1 NCOA6 FOXP4 GTF2A1L	1.57e-03	291	35	4	int:TLX3
Interaction	HSFY1 interactions	NFYC QRICH1	1.59e-03	34	35	2	int:HSFY1
Interaction	HCFC1 interactions	SP1 NCOA6 CHD8 TAF4	1.61e-03	293	35	4	int:HCFC1
Interaction	SOX13 interactions	SOX5 FOXP4	1.68e-03	35	35	2	int:SOX13
Cytoband	Xp22.11	SUPT20HL1 SUPT20HL2	1.24e-04	21	36	2	Xp22.11
Cytoband	Ensembl 112 genes in cytogenetic band chrXp22	SUPT20HL1 SUPT20HL2 MBTPS2	9.97e-04	250	36	3	chrXp22
Cytoband	Ensembl 112 genes in cytogenetic band chr6q25	SCAF8 SYNE1	7.38e-03	164	36	2	chr6q25
Cytoband	14q11.2	CHD8 TOX4	8.82e-03	180	36	2	14q11.2
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP1 SP2 SP4	6.93e-08	9	18	3	755
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	SP1 SP2 SP4 CTCF	4.84e-03	718	18	4	28
Coexpression	GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN	SP1 NCOA6 CHD8 QRICH1 CTCF	7.65e-06	200	36	5	M5870
Coexpression	KRAS.DF.V1_DN	SP1 SP2 TAF4 SYNE1	1.40e-04	193	36	4	M2861
Coexpression	GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN	NCOA6 CHD8 CTCF MYO1F	1.51e-04	197	36	4	M5877
Coexpression	GSE11924_TFH_VS_TH1_CD4_TCELL_UP	SP1 CHD8 NEURL4 SCAF8	1.57e-04	199	36	4	M3151
Coexpression	GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN	NFYA CCAR1 TOMM20 LONP2	1.60e-04	200	36	4	M6774
Coexpression	GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN	NCOA6 CHD8 CTCF MYO1F	1.60e-04	200	36	4	M5851
Coexpression	GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN	NCOA6 CHD8 CTCF MYO1F	1.60e-04	200	36	4	M5859
Coexpression	GSE27786_CD4_TCELL_VS_MONO_MAC_UP	NFYC TAF4B CTCF NEURL4	1.60e-04	200	36	4	M4833
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	SOX5 SP1 SP4 CHD8 TAF4B MBTPS2 CTCF RAD23A	3.14e-05	806	34	8	gudmap_developingGonad_e12.5_epididymis_1000
Computational	Genes in the cancer module 123.	NFYA SOX5 SP4 TOX4 TAF4 RFX2	2.73e-05	247	27	6	MODULE_123
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NFYC BPTF NCOA6 QRICH1 CTCF SCAF8	2.35e-07	178	34	6	7245_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NFYC BPTF NCOA6 QRICH1 CTCF SCAF8	2.35e-07	178	34	6	1112_DN
Drug	SP 0	SP1 SP2 SP4	3.62e-07	10	34	3	CID002742752
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	BPTF NCOA6 AMOTL2 CTCF SCAF8	5.41e-06	172	34	5	1072_DN
Drug	ADP-ribosylarginine	SP1 SP2 SP4	6.84e-06	25	34	3	CID000126311
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NFYA QRICH1 TAF4 CTCF SCAF8	7.12e-06	182	34	5	3887_DN
Drug	Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	NFYC GTF2A1 AMOTL2 MBTPS2 YLPM1	1.13e-05	200	34	5	7410_DN
Drug	aaptamine	SP1 SYNE1	1.30e-05	4	34	2	CID000122826
Drug	Sp 1 (pharmaceutical)	NFYC SP1 GTF2A1 SP4 TAF4 TAF4B CTCF	1.38e-05	548	34	7	CID000099040
Drug	3-(2-carboxyindol-3-yl)propionic acid	SP1 SP2 SP4	3.60e-05	43	34	3	CID000169313
Drug	2-pentene	SP2 SYNE1	7.74e-05	9	34	2	CID000012585
Drug	cumulene	SP2 SYNE1	7.74e-05	9	34	2	CID006324998
Drug	bis(hexamethylene)triamine	NFYA SP1 RFX2	7.99e-05	56	34	3	CID000008924
Drug	HBF4	SP2 SYNE1	9.67e-05	10	34	2	CID000028118
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NFYC BPTF CTCF SCAF8	9.93e-05	163	34	4	7453_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	BPTF NCOA6 CTCF SCAF8	1.17e-04	170	34	4	1050_DN
Drug	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	SP1 SP4	1.18e-04	11	34	2	ctd:C492909
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NFYC QRICH1 CTCF SCAF8	1.19e-04	171	34	4	1234_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NFYC BPTF CTCF SCAF8	1.25e-04	173	34	4	4665_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NFYC BPTF CTCF SCAF8	1.25e-04	173	34	4	5950_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NFYC QRICH1 CTCF SCAF8	1.28e-04	174	34	4	7105_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	BPTF NCOA6 CTCF SCAF8	1.31e-04	175	34	4	1058_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NFYC AMOTL2 CTCF SCAF8	1.34e-04	176	34	4	7499_DN
Drug	trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA	BPTF TAF4 AMOTL2 CTCF	1.34e-04	176	34	4	981_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	BPTF NCOA6 CTCF SCAF8	1.34e-04	176	34	4	6932_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BPTF SP2 CTCF SCAF8	1.36e-04	177	34	4	6340_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NFYC BPTF QRICH1 CTCF	1.39e-04	178	34	4	992_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NFYC BPTF CTCF SCAF8	1.39e-04	178	34	4	5086_DN
Drug	AC1L2HAX	SP1 SYNE1	1.42e-04	12	34	2	CID000020942
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NFYC BPTF CTCF SCAF8	1.46e-04	180	34	4	1793_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	BPTF NCOA6 CTCF SCAF8	1.52e-04	182	34	4	1891_DN
Drug	GW8510; Down 200; 10uM; PC3; HT_HG-U133A	CHD8 TAF4 AMOTL2 CTCF	1.52e-04	182	34	4	7085_DN
Drug	Thioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A	SP1 SP2 AMOTL2 YLPM1	1.52e-04	182	34	4	4989_UP
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	BPTF TAF4 CTCF SCAF8	1.58e-04	184	34	4	2321_DN
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	NFYA TOX4 LONP2 YLPM1	1.65e-04	186	34	4	3279_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	BPTF NCOA6 CTCF SCAF8	1.83e-04	191	34	4	7503_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	NFYA RNF216 GTF2A1 TOX4	1.83e-04	191	34	4	4811_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	NFYC GTF2A1 CHD8 RAD23A	1.83e-04	191	34	4	5200_DN
Drug	AC1L1B35	SP1 SP2 SP4	1.83e-04	74	34	3	CID000001263
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	NFYA MBTPS2 SYNE1 MYO1F	1.86e-04	192	34	4	4496_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	NFYA NFYC GTF2A1 MYO1F	1.86e-04	192	34	4	5206_DN
Drug	Colchicine [64-86-8]; Down 200; 10uM; MCF7; HT_HG-U133A	NFYA TOX4 MBTPS2 LONP2	1.90e-04	193	34	4	3213_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	NFYA MBTPS2 YLPM1 MYO1F	1.94e-04	194	34	4	7481_DN
Drug	Simvastatin [79902-63-9]; Down 200; 9.6uM; PC3; HT_HG-U133A	SP1 GTF2A1 SYNE1 MYO1F	1.94e-04	194	34	4	4244_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A	NFYA SP1 TOX4 MBTPS2	1.94e-04	194	34	4	5075_DN
Drug	acetoacetic ester	SP2 SYNE1	1.95e-04	14	34	2	CID000008868
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; HL60; HT_HG-U133A	NFYA SP1 TAF4B MBTPS2	2.02e-04	196	34	4	2951_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	SP1 TOX4 TAF4B MBTPS2	2.02e-04	196	34	4	7357_DN
Drug	Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; HL60; HT_HG-U133A	NFYC SP1 TOX4 MBTPS2	2.06e-04	197	34	4	1282_UP
Drug	Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A	NFYA SP1 MBTPS2 LONP2	2.06e-04	197	34	4	7419_UP
Drug	Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A	RNF216 GTF2A1 LONP2 MYO1F	2.06e-04	197	34	4	4717_DN
Drug	AC1L97MU	SP1 TAF4 GTF2A1L	2.06e-04	77	34	3	CID000414413
Drug	Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; PC3; HT_HG-U133A	NFYA RNF216 SP2 TOX4	2.10e-04	198	34	4	7275_DN
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	RNF216 MBTPS2 YLPM1 MYO1F	2.14e-04	199	34	4	3564_DN
Drug	alpha-estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A	NFYA RNF216 SYNE1 YLPM1	2.14e-04	199	34	4	1210_DN
Drug	8-azaguanine	SP1 SP4 NEURL4	2.14e-04	78	34	3	CID000008646
Drug	Stallimycin	NFYA SP1 GTF2A1	2.31e-04	80	34	3	CID000003115
Drug	2-methyleneglutarate	SP2 SYNE1	2.56e-04	16	34	2	CID000095155
Drug	benzyl bromide	SP2 SYNE1	2.90e-04	17	34	2	CID000007498
Drug	Dimethyl C7	SP1 SP4	3.26e-04	18	34	2	CID000123994
Drug	trabectedin	NFYA NFYC	3.64e-04	19	34	2	ctd:C099150
Disease	Intellectual Disability	BPTF CHD8 QRICH1 CTCF SYNE1	2.00e-04	447	36	5	C3714756
Disease	mood instability measurement	EYS QRICH1 YLPM1	5.13e-04	128	36	3	EFO_0008475
Disease	urate measurement, bone density	EYS QRICH1 TOX4 TAF4B SYNE1	8.80e-04	619	36	5	EFO_0003923, EFO_0004531
Disease	Malignant neoplasm of breast	NFYC GTF2A1 NCOA6 FOXP4 RFX2 SYNE1	1.75e-03	1074	36	6	C0006142
Disease	very low density lipoprotein cholesterol measurement	BPTF SP4 MYO1F	3.90e-03	260	36	3	EFO_0008317
Disease	body weight	SOX5 BPTF CHD8 EYS TOX4 GTF2A1L	3.90e-03	1261	36	6	EFO_0004338
Disease	pulmonary function measurement	NFYC EP400P1	4.00e-03	77	36	2	EFO_0003892
Disease	Autism Spectrum Disorders	SOX5 CHD8	4.85e-03	85	36	2	C1510586
Disease	eye color	SOX5 EYS	5.42e-03	90	36	2	EFO_0003949
Disease	multisite chronic pain	SOX5 SP4	6.02e-03	95	36	2	EFO_0010100

Protein segments in the cluster

Peptide	Gene	Start	Entry
ILQAQVPPVFLQQQQ	AMOTL2	246	Q9Y2J4
QLQVQQPQQKIQIVP	CHD8	341	Q9HCK8
QPINIGELQLVQVPV	CTCF	106	P49711
QPLLQQPQQKAGLLQ	CCAR1	266	Q8IX12
RPQLQIQQPQPQVIA	BPTF	2546	Q12830
IQQPQPQVIAVPQLQ	BPTF	2551	Q12830
PQVIAVPQLQQQVQV	BPTF	2556	Q12830
QSGVPQQIKLQLPIQ	BPTF	2586	Q12830
QVIQQNPALLPALLQ	RAD23A	246	P54725
QPIQVQVQIQGQAPQ	QRICH1	131	Q2TAL8
LEQHGLTPQQIQIPQ	LONP2	531	Q86WA8
PQAQPLILQIQSQVI	MAGEL2	331	Q9UJ55
NQAVPQICPLQIQLG	EYS	71	Q5T1H1
IQGQLVQQQQVLQGP	EP400P1	261	Q6ZTU2
ILSPPQLQALLQQQQ	FOXP4	121	Q8IVH2
TTIQPGQIIIAQPQQ	NFYC	171	Q13952
PQGQVLLQQNPMIEQ	NCOA6	701	Q14686
IIQQLPQQPLIAQIP	C21orf58	211	P58505
QVLQVVVPGINLPVN	MBTPS2	141	O43462
LIQTLQIQQQKPQPS	SCAF8	206	Q9UPN6
QIQQQKPQPSILQAL	SCAF8	211	Q9UPN6
IVVINQPLVPQLLVQ	NEURL4	1161	Q96JN8
LQQIQLVPPGQIQIQ	NFYA	101	P23511
IPQAVQVKQLVVQQP	TAF4B	521	Q92750
QQIQLNPLQPVPVVK	TAF4	781	O00268
QVIPQLQTVEGQQIQ	SP4	166	Q02446
NSLQQVQIVGQPILQ	SP4	391	Q02446
VQIVGQPILQQIQIQ	SP4	396	Q02446
QPILQQIQIQQPQQQ	SP4	401	Q02446
QQGVQLPSVLRQQQP	SUPT20HL1	711	Q3ZLR7
IPLGPQNKQLLQQQA	SYNE1	1406	Q8NF91
LPRVQQVPQQVQPVQ	RFX2	51	P48378
LNQQPREITNQVVPQ	RNF216	181	Q9NWF9
QQQILIQPQLVQGGQ	SP1	396	P08047
LLLQPQPQPQQIQLQ	SUPT20HL2	756	P0C7V6
QPQPQQIQLQTQPLR	SUPT20HL2	761	P0C7V6
QIQLQTQPLRVLQQP	SUPT20HL2	766	P0C7V6
FQPQQSVVLQQQVIP	GTF2A1	176	P52655
LQHPIQQVFQQLGQP	GTF2A1L	151	Q9UNN4
IQVQPNLTNQIQIIP	SP2	146	Q02086
LQQYQQIIQPPPHIQ	YLPM1	416	P49750
QQQIQVQGQLPPLMI	SOX5	266	P35711
GQPQQLLQVLQQTLP	TOMM20	101	Q15388
TQQQVTILQQPPPLQ	TOX4	456	O94842
QVIGIPPSIQQLVLQ	MYO1F	261	O00160